These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 27307623)

  • 21. SignalSpider: probabilistic pattern discovery on multiple normalized ChIP-Seq signal profiles.
    Wong KC; Li Y; Peng C; Zhang Z
    Bioinformatics; 2015 Jan; 31(1):17-24. PubMed ID: 25192742
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of aggregated cell-cell statistical distances within pathways unveils therapeutic-resistance mechanisms in circulating tumor cells.
    Schissler AG; Li Q; Chen JL; Kenost C; Achour I; Billheimer DD; Li H; Piegorsch WW; Lussier YA
    Bioinformatics; 2016 Jun; 32(12):i80-i89. PubMed ID: 27307648
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Seten: a tool for systematic identification and comparison of processes, phenotypes, and diseases associated with RNA-binding proteins from condition-specific CLIP-seq profiles.
    Budak G; Srivastava R; Janga SC
    RNA; 2017 Jun; 23(6):836-846. PubMed ID: 28336542
    [TBL] [Abstract][Full Text] [Related]  

  • 24. T-iDT : tool for identification of drug target in bacteria and validation by Mycobacterium tuberculosis.
    Singh NK; Selvam SM; Chakravarthy P
    In Silico Biol; 2006; 6(6):485-93. PubMed ID: 17518759
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Developing discriminate model and comparative analysis of differentially expressed genes and pathways for bloodstream samples of diabetes mellitus type 2.
    Liu C; Lu L; Kong Q; Li Y; Wu H; Yang W; Xu S; Yang X; Song X; Yang JY; Yang M; Deng Y
    BMC Bioinformatics; 2014; 15 Suppl 17(Suppl 17):S5. PubMed ID: 25559614
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vitiligo blood transcriptomics provides new insights into disease mechanisms and identifies potential novel therapeutic targets.
    Dey-Rao R; Sinha AA
    BMC Genomics; 2017 Jan; 18(1):109. PubMed ID: 28129744
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MyProteinNet: build up-to-date protein interaction networks for organisms, tissues and user-defined contexts.
    Basha O; Flom D; Barshir R; Smoly I; Tirman S; Yeger-Lotem E
    Nucleic Acids Res; 2015 Jul; 43(W1):W258-63. PubMed ID: 25990735
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A systems biology and proteomics-based approach identifies SRC and VEGFA as biomarkers in risk factor mediated coronary heart disease.
    V A; Nayar PG; Murugesan R; S S; Krishnan J; Ahmed SS
    Mol Biosyst; 2016 Jul; 12(8):2594-604. PubMed ID: 27279347
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tissue Specificity of Human Disease Module.
    Kitsak M; Sharma A; Menche J; Guney E; Ghiassian SD; Loscalzo J; Barabási AL
    Sci Rep; 2016 Oct; 6():35241. PubMed ID: 27748412
    [TBL] [Abstract][Full Text] [Related]  

  • 30. GREGOR: evaluating global enrichment of trait-associated variants in epigenomic features using a systematic, data-driven approach.
    Schmidt EM; Zhang J; Zhou W; Chen J; Mohlke KL; Chen YE; Willer CJ
    Bioinformatics; 2015 Aug; 31(16):2601-6. PubMed ID: 25886982
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Virus-human cell interactomes.
    Tafforeau L; Rabourdin-Combe C; Lotteau V
    Methods Mol Biol; 2012; 812():103-20. PubMed ID: 22218856
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitating tissue specificity of human genes to facilitate biomarker discovery.
    Vasmatzis G; Klee EW; Kube DM; Therneau TM; Kosari F
    Bioinformatics; 2007 Jun; 23(11):1348-55. PubMed ID: 17384019
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of novel VHL target genes and relationship to hypoxic response pathways.
    Maina EN; Morris MR; Zatyka M; Raval RR; Banks RE; Richards FM; Johnson CM; Maher ER
    Oncogene; 2005 Jun; 24(28):4549-58. PubMed ID: 15824735
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A random forest classifier predicts recurrence risk in patients with ovarian cancer.
    Cheng L; Li L; Wang L; Li X; Xing H; Zhou J
    Mol Med Rep; 2018 Sep; 18(3):3289-3297. PubMed ID: 30066910
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential regulation enrichment analysis via the integration of transcriptional regulatory network and gene expression data.
    Ma S; Jiang T; Jiang R
    Bioinformatics; 2015 Feb; 31(4):563-71. PubMed ID: 25322838
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel multi-network approach reveals tissue-specific cellular modulators of fibrosis in systemic sclerosis.
    Taroni JN; Greene CS; Martyanov V; Wood TA; Christmann RB; Farber HW; Lafyatis RA; Denton CP; Hinchcliff ME; Pioli PA; Mahoney JM; Whitfield ML
    Genome Med; 2017 Mar; 9(1):27. PubMed ID: 28330499
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Data set of interactomes and metabolic pathways of proteins differentially expressed in brains with Alzheimer׳s disease.
    Minjarez B; Calderón-González KG; Valero Rustarazo ML; Herrera-Aguirre ME; Labra-Barrios ML; Rincon-Limas DE; Sánchez Del Pino MM; Mena R; Luna-Arias JP
    Data Brief; 2016 Jun; 7():1707-19. PubMed ID: 27257613
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel bioinformatic identification of differentially expressed tissue-specific and cancer-related proteins from the Human Protein Atlas for biomarker discovery.
    Liu XX; Liu FJ
    Genet Mol Res; 2015 May; 14(2):4557-65. PubMed ID: 25966229
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Author Correction: Parkinson's disease and schizophrenia interactomes contain temporally distinct gene clusters underlying comorbid mechanisms and unique disease processes.
    Karunakaran KB; Jain S; Brahmachari SK; Balakrishnan N; Ganapathiraju MK
    Schizophrenia (Heidelb); 2024 Mar; 10(1):33. PubMed ID: 38480791
    [No Abstract]   [Full Text] [Related]  

  • 40. Expression of Concern: Artigas-Jerónimo et al. A Novel Combined Scientific and Artistic Approach for the Advanced Characterization of Interactomes: The Akirin/Subolesin Model.
    Vaccines Editorial Office
    Vaccines (Basel); 2020 Jul; 8(3):. PubMed ID: 32722443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.